Home eli lilly
 

Keywords :   


Tag: eli lilly

Eli Lilly and major shareholder Lilly Endowment Inc Sells 200,000 Shares

2015-06-06 06:55:55| Food - Topix.net

Eli Lilly and major shareholder Lilly Endowment Inc sold 200,000 shares of Eli Lilly and stock on the open market in a transaction dated Thursday, June 4th. The shares were sold at an average price of $77.90, for a total transaction of $15,580,000.00.

Tags: major shares sells eli

 

Eli Lilly and major shareholder Lilly Endowment Inc Sells 200,000 Shares

2015-06-06 06:16:16| Agriculture - Topix.net

Eli Lilly and major shareholder Lilly Endowment Inc sold 200,000 shares of Eli Lilly and stock on the open market in a transaction dated Thursday, June 4th. The shares were sold at an average price of $77.90, for a total transaction of $15,580,000.00.

Tags: major shares sells eli

 
 

Eli Lilly sales rep, son dead in Texas flooding

2015-06-03 01:35:28| Biotech - Topix.net

An Eli Lilly and Company sales representative was one of two dozen people who were killed in the savage flooding that devastated parts of Central Eli Lilly sales rep, son dead in Texas flooding An Eli Lilly and Company sales representative was one of two dozen people who were killed in the savage flooding that devastated parts of Central Check out this story on IndyStar.com: http://indy.st/1M2GlFE Eli Lilly and Co. has become the first company to get federal approval to sell pre-filled injection pens with a concentrated dose of mealtime insulin.

Tags: son sales dead texas

 

Lean years behind it, Eli Lilly sees growth in new drugs

2015-05-31 15:39:30| Food - Topix.net

Lean years behind it, Eli Lilly sees growth in new drugs "We had to find our true grit," CEO John Lechleiter says of past five years Check out this story on IndyStar.com: http://indy.st/1HDLXCO The loss of 60 percent of its revenue from patent expirations from 2011-2014 put Eli Lilly and Co. at risk.

Tags: new years growth drugs

 

Lean years behind it, Eli Lilly sees growth in new drugs

2015-05-31 14:26:47| Agriculture - Topix.net

Lean years behind it, Eli Lilly sees growth in new drugs "We had to find our true grit," CEO John Lechleiter says of past five years Check out this story on IndyStar.com: http://indy.st/1HDLXCO The loss of 60 percent of its revenue from patent expirations from 2011-2014 put Eli Lilly and Co. at risk.

Tags: new years growth drugs

 

Sites : [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] next »